Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Role of Serum sST2/ miR-223 as a Dual Biomarker for Disease Activity & Clinical Efficacy of SLIT in HDM-Induced Allergic Rhinitis

NCT07436208 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT07436208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07436208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Role of Serum sST2/ miR-223 as a Dual Biomarker for Disease Activity & Clinical Efficacy of SLIT in HDM-Induced Allergic Rhinitis
Lead sponsor
Zagazig University
Phase
Phase 1
Overall status
Completed
Start date
February 1, 2025
Completion date
November 30, 2025
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hdm-induced allergic rhinitis